Geron (GERN) Operating Leases (2019 - 2026)
Geron (GERN) posted Operating Leases of $1.2 million for Q1 2026, down 15.16% sequentially from $1.4 million in Q4 2025, and down 40.74% YoY from $2.1 million in Q1 2025.
Geron (GERN) Operating Leases (2019 - 2026) Analysis & Trends
Geron has reported Operating Leases for 8 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Operating Leases fell 40.74% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 40.74% YoY) and the FY2025 annual result came in at $1.4 million, down 36.23% from the prior year.
- Operating Leases retreated to $1.2 million in Q1 2026 per GERN's latest filing, from $1.4 million in the prior quarter.
- Over five years, Operating Leases peaked at $4.1 million in Q1 2022 and troughed at $1.2 million in Q1 2026.
- A 5-year average of $2.8 million and a median of $2.8 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2026: Operating Leases slipped 11.71% in 2022, then sank 40.74% in 2026.
- Over 5 years, Operating Leases stood at $3.7 million in 2022, then fell by 18.11% to $3.0 million in 2023, then decreased by 24.62% to $2.3 million in 2024, then slumped by 36.23% to $1.4 million in 2025, then dropped by 15.16% to $1.2 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $1.2 million, $1.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 3.67 Mn |
| Sep 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 4.13 Mn |
| Dec 31, 2021 | 4.27 Mn |
| Sep 30, 2021 | 4.41 Mn |